Alomone Labs
Rehovot, Israel· Est.
Alomone Labs provides premium membrane‑protein research tools, enabling fast, reproducible studies across neuroscience and disease fields.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Alomone Labs provides premium membrane‑protein research tools, enabling fast, reproducible studies across neuroscience and disease fields.
NeuroscienceCardiovascularOncologyImmunologyMetabolism
Technology Platform
Proprietary pipeline for producing membrane‑protein‑specific reagents, including recombinant toxins, polyclonal antibodies, and fluorescently labeled modulators.
Opportunities
Expansion into custom peptide/toxin synthesis and partnerships with biotech firms developing membrane‑protein therapeutics will drive growth.
Risk Factors
Intense competition from larger reagent suppliers and reliance on high‑quality peptide manufacturing could impact margins.
Competitive Landscape
Alomone differentiates itself through specialized toxin expertise and validated antibody kits, competing with companies like Abcam, MilliporeSigma, and Tocris.